NIH Halts Clinical Trials in India, Cites Uncertainty Over Compensation Rules

NIH announced June 29 that it is withdrawing clinical trial research in India, and some experts are pointing to recent stringent regulations as a possible cause. Recent amendments to Indian drug and cosmetics law have affected some NIH studies and, due to uncertainties posed by the new requirements, the institute and some grantees have suspended new patient enrollment for some ongoing interventional trials.
International Pharmaceutical Regulatory Monitor